CORCEPT THERAPEUTICS INC's Officer Joseph Douglas Lyon conducted multiple transactions on March 31 and April 1, selling a total of 200,650 shares of common stock, including several instances of shares acquired through option exercises before sale. Intensive reduction by executives typically implies the current stock price may be overvalued, which is worth investors' attention.